Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2004;110:1794-1798
Published online before print September 13, 2004, doi: 10.1161/01.CIR.0000143073.60937.50
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
110/13/1794    most recent
01.CIR.0000143073.60937.50v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chong, A. Y.
Right arrow Articles by Lip, G. Y.H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chong, A. Y.
Right arrow Articles by Lip, G. Y.H.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Heart Failure
Hazardous Substances DB
*NITROGLYCERIN
Related Collections
Right arrow Congestive
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Other Vascular biology

(Circulation. 2004;110:1794-1798.)
© 2004 American Heart Association, Inc.


Heart Failure

Endothelial Dysfunction and Damage in Congestive Heart Failure

Relation of Flow-Mediated Dilation to Circulating Endothelial Cells, Plasma Indexes of Endothelial Damage, and Brain Natriuretic Peptide

Aun Yeong Chong, MRCP; Andrew D. Blann, PhD; Jeetesh Patel, PhD; Bethan Freestone, MRCP; Elizabeth Hughes, MD; Gregory Y.H. Lip, MD

From the Haemostasis Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, England, UK.

Correspondence to Prof G.Y.H. Lip, Haemostasis Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham B18 7QH, England, UK. E-mail g.y.h.lip{at}bham.ac.uk

Received December 30, 2003; de novo received April 10, 2004; accepted June 18, 2004.

Background— Congestive heart failure (CHF) is associated with endothelial perturbation (as defined by flow-mediated endothelial-dependent vasodilation [FMD, an index of endothelial dysfunction], circulating endothelial cells [CECs, an index of endothelial damage], or plasma indexes of endothelial damage/dysfunction [eg, von Willebrand factor (vWf) and soluble thrombomodulin (sTM)]) and raised plasma levels of brain natriuretic peptide (BNP, a peptide hormone associated with left ventricular systolic dysfunction and prognosis). However, the relations between these parameters are unclear.

Methods and Results— To test the hypothesis that there is a relation between endothelial perturbation (defined by FMD, CECs, vWf, and sTM) and BNP in CHF, we studied these indexes in 30 patients with CHF who were compared with 20 age-matched control subjects. FMD, CECs, plasma vWf, and BNP levels (but not sTM) were all abnormal in patients with CHF. There were significant inverse correlations between FMD and vWf (P=0.001), CECs (P=0.002) and BNP (P=0.006) as well as a positive correlation between CECs and vWf (P=0.032). In multivariate analysis, BNP (P<0.001) and FMD (P<0.001) were both independently associated with CHF.

Conclusions— Ample evidence of endothelial cell damage/dysfunction in CHF cannot be fully explained by the variance in plasma BNP per se. Therefore, the routes by which these indexes influence the pathophysiology of CHF as well as predict adverse outcomes may be independent.


Key Words: heart failure • endothelium • von Willebrand factor • endothelium-derived factors • natriuretic peptides




This article has been cited by other articles:


Home page
ChestHome page
B. Freestone, F. Gustafsson, A. Y. Chong, P. Corell, C. Kistorp, P. Hildebrandt, and G. Y. H. Lip
Influence of Atrial Fibrillation on Plasma Von Willebrand Factor, Soluble E-Selectin, and N-Terminal Pro B-type Natriuretic Peptide Levels in Systolic Heart Failure
Chest, May 1, 2008; 133(5): 1203 - 1208.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. Demiot, F. Dignat-George, J.-O. Fortrat, F. Sabatier, C. Gharib, I. Larina, G. Gauquelin-Koch, R. Hughson, and M.-A. Custaud
WISE 2005: chronic bed rest impairs microcirculatory endothelium in women
Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H3159 - H3164.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
C. J. Boos, G. Y.H. Lip, and A. D. Blann
Circulating Endothelial Cells in Cardiovascular Disease
J. Am. Coll. Cardiol., October 17, 2006; 48(8): 1538 - 1547.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Kathiresan, P. Gona, M. G. Larson, D. Levy, C. Newton-Cheh, T. J. Wang, E. J. Benjamin, R. S. Vasan, J. A. Vita, G. F. Mitchell, et al.
Response to Letter Regarding Article, "Cross-Sectional Relations of Multiple Biomarkers From Distinct Biological Pathways to Brachial Artery Endothelial Function"
Circulation, September 5, 2006; 114(10): e384 - e384.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
C. A. Skrabal, Y. H. Choi, A. Kaminski, M. Steiner, G. Kundt, G. Steinhoff, and A. Liebold
Circulating endothelial cells demonstrate an attenuation of endothelial damage by minimizing the extracorporeal circulation.
J. Thorac. Cardiovasc. Surg., August 1, 2006; 132(2): 291 - 296.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
P. van der Harst, A. A. Voors, W. H. van Gilst, M. Bohm, and D. J. van Veldhuisen
Statins in the treatment of chronic heart failure: Biological and clinical considerations
Cardiovasc Res, August 1, 2006; 71(3): 443 - 454.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
E. Ingelsson, K. Bjorklund-Bodegard, L. Lind, J. Arnlov, and J. Sundstrom
Diurnal blood pressure pattern and risk of congestive heart failure.
JAMA, June 28, 2006; 295(24): 2859 - 2866.
[Abstract] [Full Text] [PDF]


Home page
J Am Board Fam MedHome page
R. P. Blankfield
Can Natriuretic Peptide Levels Predict the Cardiovascular Complications of COX-2 Inhibitors and Nonsteroidal Anti-inflammatory Drugs?
J Am Board Fam Med, March 1, 2006; 19(2): 178 - 182.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
O. O. Ogunshola, V. Djonov, R. Staudt, J. Vogel, and M. Gassmann
Chronic excessive erythrocytosis induces endothelial activation and damage in mouse brain
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R678 - R684.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
S. Kathiresan, P. Gona, M. G. Larson, J. A. Vita, G. F. Mitchell, G. H. Tofler, D. Levy, C. Newton-Cheh, T. J. Wang, E. J. Benjamin, et al.
Cross-Sectional Relations of Multiple Biomarkers From Distinct Biological Pathways to Brachial Artery Endothelial Function
Circulation, February 21, 2006; 113(7): 938 - 945.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
D. H. Kim, H.-B. Leu, J.-W. Chen, S.-J. Lin, H. C. Ott, D. A. Taylor, F. Bertolini, P. Mancuso, R. S. Kerbel, C. J. Boos, et al.
Circulating Endothelial Progenitor Cells
N. Engl. J. Med., December 15, 2005; 353(24): 2613 - 2616.
[Full Text] [PDF]


Home page
ChestHome page
S. M. Kawut, E. M. Horn, K. K. Berekashvili, A. C. Widlitz, E. B. Rosenzweig, and R. J. Barst
von Willebrand Factor Independently Predicts Long-term Survival in Patients With Pulmonary Arterial Hypertension
Chest, October 1, 2005; 128(4): 2355 - 2362.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. W. Lee, G. Y. H. Lip, M. Tayebjee, W. Foster, and A. D. Blann
Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes
Blood, January 15, 2005; 105(2): 526 - 532.
[Abstract] [Full Text] [PDF]